Although subcutaneous insulin infusion from portable pumps is the current optimal therapy
for type 1 diabetic patients, implantable pumps using the intraperitoneal route allow …

This review deals with the two most serious side effects encountered with insulin pump
therapy, severe hypoglycemia and diabetic ketoacidosis (DKA). Although clinical follow‐up …

Aims To determine the impact of insulin pump therapy (continuous subcutaneous insulin
infusion) on key parameters of diabetes management including quality of life in children and …

OBJECTIVE: To examine the effect of continuous subcutaneous insulin infusion (CSII)
therapy on parameters affecting long-term outcome in type 1 diabetes. STUDY DESIGN …

Purpose Current forms of insulin delivery used in the treatment of diabetes mellitus
(diabetes) include syringes, pens, and insulin pumps. Technical advantages of insulin pump …

Background The risk of developing long-term complications of type 1 diabetes (T1D) is
related to glycaemic control and is reduced by the use of intensive insulin treatment …

Objective: To document current practices using continuous subcutaneous insulin infusion
(CSII) by downloading electronically the 90‐d pump data held within the pump memory and …

The introduction of continuous subcutaneous insulin infusion in clinical care has led to more
optimal glycemic and quality-of-life outcomes, compared with multiple daily injections (MDI) …

Objective Continuous subcutaneous insulin infusion (CSII) and multiple daily insulin
injections (MDI) are two methods currently used to manage type I diabetes mellitus (T1DM) …

Objectives To investigate in a large population the proportion of daily basal insulin dose
(BD) to daily total insulin dose (TD)(BD/TD) and its association with glycated hemoglobin …